Ethosuximide Pregnancy and Breastfeeding Warnings
Ethosuximide is also known as: Zarontin
Ethosuximide Pregnancy Warnings
Ethosuximide has not been formally assigned to a pregnancy category by the FDA. Ethosuximide has been assigned to pregnancy Risk Factor C by Briggs et al. Animal studies have not been reported. There are no controlled data in human pregnancy. An increased risk of congenital malformations have been associated with the use of anticonvulsants (including ethosuximide) in epileptic women during pregnancy. Abnormalities reported with ethosuximide use have included spontaneous hemorrhage in the neonate, patent ductus arteriosus, cleft lip and/or palate, mongoloid facies, short neck, altered palmar crease, an accessory nipple, and hydrocephalus. Anomalies associated with anticonvulsant use in pregnancy included neural tube defects, cleft lips, cleft palates, cardiac defects, and microcephaly. The manufacturer states that ethosuximide should only be administered during pregnancy when there are no alternatives and benefit outweighs risk.
To provide information regarding the effects of in utero exposure to ethosuximide, physicians are advised to recommend that pregnant patients taking ethosuximide enroll in the North American Antiepileptic Drug (NAAED) Pregnancy Registry. This can be done by calling the toll free number 1-888-233-2334, and must be done by patients themselves. Information on the registry can also be found at the website http://www.aedpregnancyregistry.org/.
Ethosuximide Breastfeeding Warnings
Ethosuximide is excreted into human milk Concentrations found in breast milk are comparable to the maternal serum. The effects in the nursing infant are unknown. Ethosuximide is considered compatible with breast-feeding by the American Academy of Pediatrics.
- Ethosuximide use while Breastfeeding (in more detail)
- ethosuximide Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.